That singular focus means every decision we make, from physician recruitment to technology development to pharmacy partnerships, is oriented around delivering the best possible weight loss outcomes
If you observe any changes in skin color, irritation, or discomfort, change the injection site
Provide spacing for airflow
FAQs for GLUTAT Tablet Q1
Our Oral GLP-1 Programme Proprietary delivery technology microencapsulates peptides for oral delivery to a specific area of the gut, using pH sensitive release mechanism to deliver the drug to its intended site of action Potential to overcome oral delivery challenges of peptide-based biologicals Effectiveness of the technology has already been validated via the commercialisation of encapsulated oral probiotics and nutraceuticals by AnaBio Technologies, our collaborative partner Proof of Concept Trial Proof of Concept Trial Progressing towards proof of concept trial to determine that a GLP-1R agonist can be successfully delivered orally in humans expected to commence H2 2026, with the potential for partnering on positive data
Glutathione IV introduces a combination of rich antioxidants in the bloodstream through a vein